We’ve covered Covidien’s pulse oximetry devices before, as recently as September when certain of their newest devices gained FDA and CE mark clearance to market. Now long time bedfellow GE Healthcare will be integrating Covidien’s Nellcor™ pulse oximetry with OxiMax™ technology into its Giraffe® and Panda® infant warmers, in a move which will help clinicians safely monitor infants for life-threatening and respiratory complications.
Each year an estimated 10 percent of the four million infants born every year in teh U.S. require some assistance in the delivery room with intensive resuscitation required in one percent of all deliveries.
By enabling continuous, accurate monitoring of blood oxygenation within minutes of birth, fully integrated Nellcor SpO2 monitoring in the GE Giraffe and Panda warmers support the Neonatal Resuscitation Program™ guidelines of the American Academy of Pediatrics and other local and regional resuscitation guidelines.
In a press release issued this week, Covidien says that integrating Nellcor SpO2 monitoring, along with the SatSeconds alarm management system, GE’s Giraffe and Panda warmers will have enhanced respiratory support and resuscitation capabilities and helps clinicians safely monitor and screen infants for life-threatening cardiac and respiratory complications, as well as standardise resuscitation protocols across the perinatal care area.
“For more than 25 years, clinicians have relied on our Nellcor cardiac-based pulse oximetry and sensor portfolio to accurately and safely monitor babies in NICU and labor and delivery departments,” said Robert J. White, President, Respiratory and Monitoring Solutions, Covidien. “The ability to incorporate the Nellcor line into existing and new GE Giraffe and Panda infant warmers greatly expands access to our trusted technologies that clinicians can rely on for ensuring the highest standard of infant care.”
Panda and Giraffe are U.S. registered trademarks of GE Healthcare or its affiliates or licensors.